VEEVA SYSTEMS INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Veeva Systems (VEEV) disclosed EVP Daniel J. Rizzo's shareholdings in a Form 3 filing. Rizzo holds 11,688 Class A shares, stock options with exercise prices ranging from $154.00 to $275.82, and restricted stock units (RSUs) vesting between 2026 and 2030. The filing details existing equity awards, not new transactions.
Veeva Systems VEEV announced a global rollout of its Vault CRM with Amgen AMGN, extending a decade-long partnership. The deal supports Amgen's commercial operations and reinforces Veeva's commercial business, which recently reported its best CRM quarter. Veeva's stock has gained 16.8% year-to-date, outperforming its industry and the S&P 500.
Veeva Systems (VEEV) launched Falcon Router, an AI agent to automate triage and routing of safety reports, quality complaints, and medical inquiries for biopharmas. It will initially support email and web intake, integrating with Veeva's existing platforms. The product is set for early adopter availability in January 2027. According to the company, the tool aims to improve efficiency and patient focus. Veeva serves over 1,500 life sciences customers.
Over the past 7 days, AlphAI's AI scored 5 news stories mentioning VEEV (VEEVA SYSTEMS INC). Coverage has skewed bullish: 4 bullish, 1 neutral, and 0 bearish.
Recent VEEV coverage spans financial news, technology and mergers & acquisitions.
In the last 30 days, VEEV insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($3.3M). The most active reporter was Schwenger Thomas D., Pres. & Chief Customer Officer, with 2 filings. 67% of those filings were made under pre-arranged Rule 10b5-1 plans.
Minor insider holding disclosure with no new purchase or sale; limited price impact.
Potential revenue uplift and cross‑sell opportunities for Veeva.
Potential upside for Veeva as the new solution may attract biopharma customers and drive SaaS revenue growth.
Analyst upgrade may lift sentiment and support price appreciation.
Merger could expand Veeco's product portfolio and market exposure.
AlphAI scores every news story that mentions VEEV with an AI model for sentiment and relevance, and aggregates insider trades from VEEVA SYSTEMS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Veeva Systems (VEEV) disclosed EVP Daniel J. Rizzo's shareholdings in a Form 3 filing. Rizzo holds 11,688 Class A shares, stock options with exercise prices ranging from $154.00 to $275.82, and restricted stock units (RSUs) vesting between 2026 and 2030. The filing details existing equity awards, not new transactions.
1 min readVeeva Systems VEEV announced a global rollout of its Vault CRM with Amgen AMGN, extending a decade-long partnership. The deal supports Amgen's commercial operations and reinforces Veeva's commercial business, which recently reported its best CRM quarter. Veeva's stock has gained 16.8% year-to-date, outperforming its industry and the S&P 500.
2 min readVeeva Systems (VEEV) launched Falcon Router, an AI agent to automate triage and routing of safety reports, quality complaints, and medical inquiries for biopharmas. It will initially support email and web intake, integrating with Veeva's existing platforms. The product is set for early adopter availability in January 2027. According to the company, the tool aims to improve efficiency and patient focus. Veeva serves over 1,500 life sciences customers.
1 min readCFRA upgraded Veeva Systems (VEEV) to Buy with a new price target. The consensus rating is Moderate Buy with an average target of $293.57. Veeva reported Q2 revenue of $927.96M and net profit of $273.43M, up from $789.08M and $200.31M last year. Insider sentiment is negative, with 63 insiders selling shares.
1 min readAxcelis Technologies (ACLS) expects mid-single-digit revenue growth in 2026 and 2027, with 2027 estimates at $981M and EPS of $5.29. Aftermarket revenue grew 35% YoY, but margins fell. ACLS trades at a premium valuation, with a forward P/E of 21.2X. A merger with Veeco Instruments is pending regulatory approval.
2 min readVeeva Systems (VEEV) announced that Amgen will deploy Veeva Vault CRM globally. Amgen aims to accelerate therapy delivery, while Veeva highlights the CRM suite's role in improving patient outcomes. The collaboration spans over a decade.
1 min readVeeva Systems (VEEV) officer Thomas D. Schwenger filed a Rule 144 notice to sell 3,000 shares worth $787,200. He previously sold 51,000 shares for $12.8M via 10b5-1 plans in the past three months. VEEV has 161.9M shares outstanding.
1 min readVeeva Systems (VEEV) launched Veeva Falcon Safety, an AI-driven tool for biopharma clients. Its shares rose 8.65% in 30 days and 64.47% in 90 days, despite a 5.08% drop over one year. Analysts debate its valuation, with some seeing it as 31.5% undervalued at $262.40, while others caution about risks like slow adoption or reduced client spending.
2 min readHung Priscilla sold 750 shares of VEEVA SYSTEMS INC (VEEV) at $261.04 ($0.20M total) on 2026-09-09.
2 min readVeeva Systems reported a 37% increase in net income to $273.4M and raised fiscal 2027 revenue guidance to $3.682B-$3.687B. Michael Burry trimmed his position but remains bullish, citing the company's intrinsic value and growth potential. Analysts expect Q3 EPS of $1.68 and have raised price targets, with a consensus 'Moderate Buy' rating and $292.52 average target.
2 min read
